| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
02-27-2017, 01:10 PM
|
#1 | ||
|
|||
|
News Gatherer
Community Support Team
|
FierceBiotech Pharma Two B raises $30M for Parkinson's phase 3 from Biogen-backed fund, adds ex-Pfizer CEO to board FierceBiotech Pharma Two B has raised $30 million (â?¬28 million) to complete a phase 3 trial of its Parkinson's asset P2B001. The round provides a hint of the impact of the recently-founded Israel Biotech Fund (IBF), which led the investment and is adding ex-Pfizer ... Israel's Pharma Two B raises $30 mln for trial of Parkinson's treatmentReuters Pharma Two B raises $30m for Parkinson's treatment trialGlobes Pharma Two B Completes $30M Third Financing RoundFinSMEs (blog) all 4 news articles » More... |
||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Serono spinout raises â?¬29M for phase 2 Parkinson's trials - FierceBiotech | Parkinson's News | |||
| Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Par | Parkinson's Disease | |||
Pharma Two B raises $30M for Parkinson's phase 3 from Biogen-backed fund, adds ex-Pfi
Linear Mode
